Proof of concept study on early forecasting of antimicrobial resistance in hospitalized patients using machine learning and simple bacterial ecology data.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: The primary proof-of-concept uses machine learning on 44,026 hospital microbiology records to estimate antimicrobial susceptibility before antibiogram availability, with stage-specific held-out performance. Evidence is retrospective at one hospital and does not show prospective treatment changes or outcomes.
Technology: The primary proof-of-concept uses machine learning on 44,026 hospital microbiology records to estimate antimicrobial susceptibility before antibiogram availability, with stage-specific held-out performance. Evidence is retrospective at one hospital and does not show prospective treatment changes or outcomes.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The primary proof-of-concept uses machine learning on 44,026 hospital microbiology records to estimate antimicrobial susceptibility before antibiogram availability, with stage-specific held-out performance. Evidence is retrospective at one hospital and does not show prospective treatment changes or outcomes.
- Limitation / still unknown
- The primary proof-of-concept uses machine learning on 44,026 hospital microbiology records to estimate antimicrobial susceptibility before antibiogram availability, with stage-specific held-out performance. Evidence is retrospective at one hospital and does not show prospective treatment changes or outcomes.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/10.1038/s41598-024-71757-w
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.